363 related articles for article (PubMed ID: 30006464)
1. MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage.
Harriff MJ; McMurtrey C; Froyd CA; Jin H; Cansler M; Null M; Worley A; Meermeier EW; Swarbrick G; Nilsen A; Lewinsohn DA; Hildebrand W; Adams EJ; Lewinsohn DM
Sci Immunol; 2018 Jul; 3(25):. PubMed ID: 30006464
[TBL] [Abstract][Full Text] [Related]
2. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
Lepore M; Lewinsohn DA; Lewinsohn DM
Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
[TBL] [Abstract][Full Text] [Related]
4. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
[TBL] [Abstract][Full Text] [Related]
5. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
6. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil.
Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W
J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698
[TBL] [Abstract][Full Text] [Related]
7. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
Keller AN; Eckle SB; Xu W; Liu L; Hughes VA; Mak JY; Meehan BS; Pediongco T; Birkinshaw RW; Chen Z; Wang H; D'Souza C; Kjer-Nielsen L; Gherardin NA; Godfrey DI; Kostenko L; Corbett AJ; Purcell AW; Fairlie DP; McCluskey J; Rossjohn J
Nat Immunol; 2017 Apr; 18(4):402-411. PubMed ID: 28166217
[TBL] [Abstract][Full Text] [Related]
8. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
9. Production of MR1 Tetramers Loaded with Microbial Ligands.
Ladd NA; Froyd CA; Adams EJ
Methods Mol Biol; 2020; 2098():191-207. PubMed ID: 31792824
[TBL] [Abstract][Full Text] [Related]
10. Functionally diverse human T cells recognize non-microbial antigens presented by MR1.
Lepore M; Kalinichenko A; Calogero S; Kumar P; Paleja B; Schmaler M; Narang V; Zolezzi F; Poidinger M; Mori L; De Libero G
Elife; 2017 May; 6():. PubMed ID: 28518056
[TBL] [Abstract][Full Text] [Related]
11. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
[TBL] [Abstract][Full Text] [Related]
12. Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells.
Jin H; Ladd NA; Peev AM; Swarbrick GM; Cansler M; Null M; Boughter CT; McMurtrey C; Nilsen A; Dobos KM; Hildebrand WH; Lewinsohn DA; Adams EJ; Lewinsohn DM; Harriff MJ
Sci Rep; 2022 Dec; 12(1):22539. PubMed ID: 36581641
[TBL] [Abstract][Full Text] [Related]
13. Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity.
Dias J; Sobkowiak MJ; Sandberg JK; Leeansyah E
J Leukoc Biol; 2016 Jul; 100(1):233-40. PubMed ID: 27034405
[TBL] [Abstract][Full Text] [Related]
14. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage.
Gold MC; McLaren JE; Reistetter JA; Smyk-Pearson S; Ladell K; Swarbrick GM; Yu YY; Hansen TH; Lund O; Nielsen M; Gerritsen B; Kesmir C; Miles JJ; Lewinsohn DA; Price DA; Lewinsohn DM
J Exp Med; 2014 Jul; 211(8):1601-10. PubMed ID: 25049333
[TBL] [Abstract][Full Text] [Related]
15. Recognition of the antigen-presenting molecule MR1 by a Vδ3
Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
[TBL] [Abstract][Full Text] [Related]
16. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
[TBL] [Abstract][Full Text] [Related]
17. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
18. Multiple Isomers of Photolumazine V Bind MR1 and Differentially Activate MAIT Cells.
Krawic JR; Ladd NA; Cansler M; McMurtrey C; Devereaux J; Worley A; Ahmed T; Froyd C; Kulicke CA; Swarbrick G; Nilsen A; Lewinsohn DM; Adams EJ; Hildebrand W
J Immunol; 2024 Mar; 212(6):933-940. PubMed ID: 38275935
[TBL] [Abstract][Full Text] [Related]
19. MR1-Restricted T Cells Are Unprecedented Cancer Fighters.
Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G
Front Immunol; 2020; 11():751. PubMed ID: 32411144
[TBL] [Abstract][Full Text] [Related]
20. Differential antigenic requirements by diverse MR1-restricted T cells.
Seneviratna R; Redmond SJ; McWilliam HE; Reantragoon R; Villadangos JA; McCluskey J; Godfrey DI; Gherardin NA
Immunol Cell Biol; 2022 Feb; 100(2):112-126. PubMed ID: 34940995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
